– BlueFive Capital, a global investment firm, announced the closing of its Onyx Fund I.
– The fund is $3 billion and registered with the ADGM.
– It targets opportunistic technology and growth capital investments in the US and Europe.
– Focus areas include artificial intelligence, biotechnology, and advanced computing.
– The fund seeks businesses where disruptive potential meets scalable commercial application.
– Anchored by opportunistic sovereign capital from across the GCC.
– Reflects alignment between GCC long-term investment priorities and exposure to foundational technological disruption in Western markets.
– Hazem Ben-Gacem, founder and CEO of BlueFive Capital, highlighted the fund’s focus on computational and biological intelligence.
– ADGM provides a forward-looking regulatory ecosystem suitable for a fund of global ambition.
– Onyx Fund I plans to make several technology and biotechnology investments in the US in the coming months.
